ArticlePain2022

Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents.

Joel Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.